CompletedNot Applicable

Cognitive-behavioral Therapy for Generalized Anxiety Disorder in Primary Care

Sweden64 participantsStarted 2018-06-15

Plain-language summary

The feasibilty and preliminary comparative effectiveness of two methods of cognitive-behavioral therapy - metacognitive therapy and intolerance of uncertainty therapy - for primary care patients with generalized anxiety disorder is investigated in a pilot study using a randomized controlled design. Purpose of the study is to examine the feasibility of a full-scale randomized controlled trial. Research questions primarily concern recruitment, measurement, and adherence.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Primary diagnosis of generalized anxiety disorder * Age 18 years or above * Being able to understand and speak Swedish without interpreter support Exclusion Criteria: * Psychosis, bipolar disorder, severe depressive symptoms, risk of suicid, substance use disorder, intellectual disability * Simultaneous psychological treatment * If pharmacological treatment, it needs to be stable prior to and during treatment

What they're measuring

Penn State Worry Questionnaire - Measure of Symptom Change

Timeframe: Change from baseline symptoms at 12 weeks

Trial details

NCT IDNCT03621371

SponsorKarolinska Institutet

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-11-30

Results submitted2024-07-04

View on ClinicalTrials.gov More Generalized Anxiety Disorder trials